AIM ImmunoTech Inc. is an immuno-pharma company located in Ocala, Florida that focuses on developing therapeutics to treat viral diseases, immune-deficiency disorders, and various types of cancers. Among its products are Ampligen, a drug of macromolecular ribonucleic acid molecules that targets chronic fatigue syndrome, and Alferon N Injection, an injectable formulation of natural alpha interferon that treats genital warts. AIM ImmunoTech Inc. has agreements with several organizations in the medical industry and is actively researching the use of Ampligen to treat a variety of diseases, including COVID-19 and post-COVID conditions.